Rosalind Advisors, Inc.: 13F holdings
CIK 16226272026Q2
| Positions | 35 |
|---|---|
| Reported value | $269.2m |
| Filed | 2026-08-14 |
Top 10 holdings
| Security | Shares | Value | Weight |
|---|---|---|---|
| DELCATH SYSTEMS, INC. | 3,300,389 | $41.6m | 15.4% |
| FENNEC PHARMACEUTICALS INC | 3,188,001 | $34.3m | 12.7% |
| XERIS BIOPHARMA HOLDINGS INC | 2,908,981 | $23.0m | 8.6% |
| SAVARA INC | 3,178,121 | $19.6m | 7.3% |
| VERASTEM INC | 3,986,509 | $15.2m | 5.7% |
| X4 PHARMACEUTICALS INC | 3,214,766 | $15.0m | 5.6% |
| EYEPOINT PHARMACEUTICALS INC | 988,230 | $14.1m | 5.2% |
| CYBIN INC | 1,956,814 | $12.9m | 4.8% |
| VOR BIOPHARMA INC | 648,600 | $11.9m | 4.4% |
| PCVX VAXCYTE INC | 200,000 | $11.6m | 4.3% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1622627")Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.